Who is sponsoring NCT04160650?

NCT04160650 is sponsored by University of Turku.

What condition does NCT04160650 study?

NCT04160650 studies Patient Empowerment, Patient Activation, Self Care, Cancer of Colon, Cancer of Rectum.

Is NCT04160650 still recruiting?

NCT04160650 is currently completed. Last updated 27 May 2022.

Last reviewed 2022-05-27 · How we verify

NCT04160650

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy

Completed NA Last updated 27 May 2022

What this trial tests

NA trial testing Educational nursing intervention on nutrition intake related chemotherapy induced side-effects' self-care among the patients with colorectal cancer in Patient Empowerment in 82 participants. Completed in 15 March 2022.

Timeline

21 October 2019

Primary endpoint
15 March 2022

15 March 2022

Quick facts

Lead sponsor	University of Turku
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	82
Start date	21 October 2019
Primary completion	15 March 2022
Estimated completion	15 March 2022
Sites	1 location across Finland

Drugs / interventions tested

Educational nursing intervention on nutrition intake related chemotherapy induced side-effects' self-care among the patients with colorectal cancer

Conditions studied

Patient Empowerment — all drugs for Patient Empowerment →
Patient Activation — all drugs for Patient Activation →
Self Care — all drugs for Self Care →
Cancer of Colon — all drugs for Cancer of Colon →

Sponsor

University of Turku

Who can join

Adults 18 to 85, any sex, with Patient Empowerment or Patient Activation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prevalence of malnutrition is common among patients with colorectal cancer. Chemotherapy induced side effects may impact negatively on nutrition intake thus increase the risk of malnutrition and serious complications for patients. Purpose is to test the effect of empowering education on activation and knowledge level among patients with colorectal cancer during the chemotherapy. Secondary outcomes are quality of life and malnutrition. A two-arm, single center, patient blinded superiority trial with stratified randomization (1:1) and with repeated measures is used to measure the effectiveness of face-to-face education on nutrition intake related chemotherapy induced side-effects' self-care compared to standard care. Eligibility criteria are adult patients diagnosed with colorectal cancer and receiving intra venous chemotherapy treatment. Patients are recruited in one university hospital outpatient clinic in Finland. Experienced oncology nurse delivers the intervention two weeks after the first chemotherapy. Primary outcomes are activation in self-care and knowledge level. Secondary outcomes are quality of life and risk of malnutrition measured at baseline (M0) and after eight (M1) and 16 weeks (M2) after the intervention. The study will provide knowledge of nurse-led educational intervention on self-care among patients with colorectal cancer. The findings will contribute to patient education and self-care, thus better quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Empowering patient education on self-care activity among patients with colorectal cancer - a research protocol for a randomised trial.
Tuominen L, Ritmala-Castrén M, Nikander P, Mäkelä S, et al · · 2021 · cited 4× · PMID 34112154 · DOI 10.1186/s12912-021-00617-z

Verify or expand the search:

Other recruiting trials for Patient Empowerment

Currently open trials in the same condition.

NCT06986824 — Perineal Massage Using A Pelvic Wand During Pregnancy · Phase 4 · recruiting

Other University of Turku trials

Trials by the same sponsor.

NCT07084389 — A Financial Social Work Intervention for Families With Complex Financial Difficulties (FinSoc) · NA · recruiting
NCT06886581 — Online Training Course to Improve Evidence-based Leadership · NA · recruiting
NCT06856408 — Power of Growth - Digitally Assisted Intervention for the Early Childhood Educators' Self-efficacy Teamwork and Children · NA · recruiting
NCT06627868 — Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue · NA · recruiting
NCT06284772 — FINRISK 2002 Re-examination · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04160650 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turku
Last refreshed: 27 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing